These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21575129)

  • 1. Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.
    Meltzer ME; Hasstedt SJ; Vossen CY; Callas PW; DE Groot PG; Rosendaal FR; Lisman T; Bovill EG
    J Thromb Haemost; 2011 Jul; 9(7):1383-90. PubMed ID: 21575129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.
    Meltzer ME; Lisman T; Doggen CJ; de Groot PG; Rosendaal FR
    PLoS Med; 2008 May; 5(5):e97. PubMed ID: 18462012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.
    Meltzer ME; Lisman T; de Groot PG; Meijers JC; le Cessie S; Doggen CJ; Rosendaal FR
    Blood; 2010 Jul; 116(1):113-21. PubMed ID: 20385790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome.
    Hoekstra J; Guimarães AH; Leebeek FW; Darwish Murad S; Malfliet JJ; Plessier A; Hernandez-Guerra M; Langlet P; Elias E; Trebicka J; Primignani M; Garcia-Pagan JC; Valla DC; Rijken DC; Janssen HL;
    Blood; 2010 Jan; 115(2):388-95. PubMed ID: 19965669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.
    Colucci M; Binetti BM; Tripodi A; Chantarangkul V; Semeraro N
    Blood; 2004 Mar; 103(6):2157-61. PubMed ID: 14630828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.
    Natorska J; Corral J; de la Morena-Barrio ME; Bravo-Pérez C; Bagoly Z; Bereczky Z; Treliński J; Witkowski M; Klajmon A; Undas A; Ząbczyk M
    Thromb Haemost; 2023 Sep; 123(9):880-891. PubMed ID: 37201530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome scan of venous thrombosis in a pedigree with protein C deficiency.
    Hasstedt SJ; Scott BT; Callas PW; Vossen CY; Rosendaal FR; Long GL; Bovill EG
    J Thromb Haemost; 2004 Jun; 2(6):868-73. PubMed ID: 15140118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred.
    Bovill EG; Hasstedt SJ; Callas PW; Valliere JE; Scott BT; Bauer KA; Long GL
    Thromb Haemost; 2000 Mar; 83(3):366-70. PubMed ID: 10744139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A locus on chromosome 13 influences levels of TAFI antigen in healthy Mexican Americans.
    Warren DM; Cole SA; Dyer TD; Soria JM; Souto JC; Fontcuberta J; Blangero J; Maccluer JW; Almasy L
    Hum Biol; 2006 Jun; 78(3):329-39. PubMed ID: 17216805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusion of the alpha2 subunit of platelet-activating factor acetylhydrolase 1b (PAFAH1B2) as a prothrombotic gene in a protein C-deficient kindred and population-based case-control sample.
    Hasstedt SJ; Scott BT; Rosendaal FR; Callas PW; Vossen CY; Long GL; Bovill EG
    Thromb Haemost; 2007 Sep; 98(3):587-92. PubMed ID: 17849047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological variation in tPA-induced plasma clot lysis time.
    Talens S; Malfliet JJ; Rudež G; Spronk HM; Janssen NA; Meijer P; Kluft C; de Maat MP; Rijken DC
    Thromb Haemost; 2012 Oct; 108(4):640-6. PubMed ID: 22836204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis.
    Karasu A; Baglin TP; Luddington R; Baglin CA; van Hylckama Vlieg A
    Br J Haematol; 2016 Mar; 172(6):947-53. PubMed ID: 26773756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred.
    Scott BT; Bovill EG; Callas PW; Hasstedt SJ; Leppert MF; Valliere JE; Varvil TS; Long GL
    Thromb Haemost; 2001 Jan; 85(1):82-7. PubMed ID: 11204593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor IX-Padua enhances the fibrinolytic resistance of plasma clots.
    Ammollo CT; Semeraro F; Colucci M; Simioni P
    Thromb Haemost; 2014 Feb; 111(2):226-32. PubMed ID: 24136406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.
    Ding Q; Yang L; Zhao X; Wu W; Wang X; Rezaie AR
    Thromb Haemost; 2017 Feb; 117(3):479-490. PubMed ID: 27975099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis.
    Mertens JC; Claesen K; Leenaerts D; Sim Y; Lambeir AM; Hendriks D
    J Thromb Haemost; 2019 Jun; 17(6):878-884. PubMed ID: 30887647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 Diabetes.
    Bryk AH; Konieczynska M; Rostoff P; Broniatowska E; Hohendorff J; Malecki MT; Undas A
    Thromb Haemost; 2019 Feb; 119(2):213-222. PubMed ID: 30605917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecule 1: a novel risk factor for venous thrombosis.
    Hasstedt SJ; Bezemer ID; Callas PW; Vossen CY; Trotman W; Hebbel RP; Demers C; Rosendaal FR; Bovill EG
    Blood; 2009 Oct; 114(14):3084-91. PubMed ID: 19643986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.